Ignite Creation Date:
2024-05-06 @ 8:21 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06341660
Status:
RECRUITING
Last Update Posted:
2024-04-02
First Post:
2024-03-13
Brief Title:
To Evaluate the Safety and Tolerability of Carbognilumab Combined With Chemotherapy as the First-line Treatment for Patients With KEAP1 Mutated Advanced or Postoperative Recurrent Non-small Cell Lung Cancer NSCLC
Sponsor:
Organization:
Guangzhou Institute of Respiratory Disease